Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xenetic Biosciences (XBIO) Profit After Tax (2023 - 2025)

Xenetic Biosciences (XBIO) has disclosed Profit After Tax for 6 consecutive years, with -$509940.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Profit After Tax fell 16.78% year-over-year to -$509940.0, compared with a TTM value of -$3.2 million through Sep 2025, up 22.59%, and an annual FY2024 reading of -$4.0 million, up 4.22% over the prior year.
  • Profit After Tax was -$509940.0 for Q3 2025 at Xenetic Biosciences, up from -$688703.0 in the prior quarter.
  • Across five years, Profit After Tax topped out at -$436671.0 in Q3 2024 and bottomed at -$1.3 million in Q2 2024.
  • Average Profit After Tax over 3 years is -$926967.0, with a median of -$1.1 million recorded in 2023.
  • Peak annual rise in Profit After Tax hit 58.63% in 2024, while the deepest fall reached 39.53% in 2024.
  • Year by year, Profit After Tax stood at -$1.2 million in 2023, then grew by 9.99% to -$1.1 million in 2024, then skyrocketed by 51.64% to -$509940.0 in 2025.
  • Business Quant data shows Profit After Tax for XBIO at -$509940.0 in Q3 2025, -$688703.0 in Q2 2025, and -$903141.0 in Q1 2025.